Lv6
2879 积分 2023-08-26 加入
Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial
10天前
已完结
Synergistic Integration of mRNA-LNP with CAR-Engineered Immune Cells: Pioneering Progress in Immunotherapy
22天前
已完结
Chimeric Antigen Cytotoxic Receptors for In-Vivo Engineering of Tumor-targeting Natural Killer Cells
22天前
已关闭
Effective targeting of CD19 positive primary B-ALL cells using CAR-NK cells generated with mRNA-LNPs
22天前
已完结
Chimeric Antigen Cytotoxic Receptors for In-Vivo Engineering of Tumor-targeting Natural Killer Cells
22天前
已关闭
Chimeric Antigen Cytotoxic Receptors for In-Vivo Engineering of Tumor-targeting Natural Killer Cells
22天前
已关闭
Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC
1个月前
已完结
Radical Minimally Invasive Surgery After Immuno-chemotherapy in Initially-unresectable Stage IIIB Non-small cell Lung Cancer
1个月前
已完结
Dictating the spatial-temporal delivery of molecular adjuvant and antigen for the enhanced vaccination
1个月前
已完结
[Chinese expert consensus on the diagnosis and treatment of pneumonia in the elderly (2024 Edition)]
1个月前
已完结
皖公网安备34019202002308
